Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Survival among pancreaticoduodenectomy patients treated for pancreatic head cancer <1 or 2 cm.

Franko J, Hugec V, Lopes TL, Goldman CD.

Ann Surg Oncol. 2013 Feb;20(2):357-61. doi: 10.1245/s10434-012-2621-y. Epub 2012 Sep 1.

PMID:
22941171
2.
3.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

4.

Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.

Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, Jaques BC, Charnley RM, White SA.

Eur J Surg Oncol. 2012 Apr;38(4):333-9. doi: 10.1016/j.ejso.2011.12.020. Epub 2012 Feb 7.

PMID:
22317758
5.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
6.

Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.

Fortner JG, Klimstra DS, Senie RT, Maclean BJ.

Ann Surg. 1996 Feb;223(2):147-53.

7.

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.

Pancreas. 2008 Jan;36(1):50-5. doi: 10.1097/MPA.0b013e31812575df.

PMID:
18192881
8.

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.

Gut. 2002 Nov;51(5):717-22.

9.

Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.

Bhatti I, Peacock O, Awan AK, Semeraro D, Larvin M, Hall RI.

World J Surg. 2010 Apr;34(4):768-75. doi: 10.1007/s00268-009-0336-4.

PMID:
20052471
10.

Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.

van Geenen RC, van Gulik TM, Offerhaus GJ, de Wit LT, Busch OR, Obertop H, Gouma DJ.

Eur J Surg Oncol. 2001 Sep;27(6):549-57.

PMID:
11520088
11.

Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.

Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M.

World J Surg. 2003 Mar;27(3):324-9. Epub 2003 Feb 27.

PMID:
12607060
12.

Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.

Zacharias T, Jaeck D, Oussoultzoglou E, Neuville A, Bachellier P.

J Gastrointest Surg. 2007 Mar;11(3):350-6.

PMID:
17458610
13.

Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.

Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP.

BMC Cancer. 2008 Jun 11;8:170. doi: 10.1186/1471-2407-8-170.

14.

Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report.

Masui T, Kubota T, Aoki K, Nakanishi Y, Miyamoto T, Nagata J, Morino K, Fukugaki A, Takamura M, Sugimoto S, Onuma H, Tokuka A.

World J Surg Oncol. 2013 Aug 14;11(1):195. doi: 10.1186/1477-7819-11-195.

15.

Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization.

van Roest MH, Gouw AS, Peeters PM, Porte RJ, Slooff MJ, Fidler V, de Jong KP.

Ann Surg. 2008 Jul;248(1):97-103. doi: 10.1097/SLA.0b013e31817b6609.

PMID:
18580212
16.

Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy?

Lad NL, Squires MH, Maithel SK, Fisher SB, Mehta VV, Cardona K, Russell MC, Staley CA, Adsay NV, Kooby DA.

Ann Surg Oncol. 2013 Oct;20(11):3626-33. doi: 10.1245/s10434-013-3080-9. Epub 2013 Jul 10.

PMID:
23838908
17.

Predicting survival after surgical resection for pancreatic ductal adenocarcinoma.

Moon HJ, An JY, Heo JS, Choi SH, Joh JW, Kim YI.

Pancreas. 2006 Jan;32(1):37-43.

PMID:
16340742
18.

Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?

Crippa S, Partelli S, Zamboni G, Barugola G, Capelli P, Inama M, Bassi C, Pederzoli P, Falconi M.

Surgery. 2012 Sep;152(3 Suppl 1):S112-9. doi: 10.1016/j.surg.2012.05.017. Epub 2012 Jul 3.

PMID:
22766365
19.

Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.

La Torre M, Cavallini M, Ramacciato G, Cosenza G, Rossi Del Monte S, Nigri G, Ferri M, Mercantini P, Ziparo V.

J Surg Oncol. 2011 Nov 1;104(6):629-33. doi: 10.1002/jso.22013. Epub 2011 Jun 28.

PMID:
21713779
20.

Prognostic factors after resection of pancreatic cancer.

Ueda M, Endo I, Nakashima M, Minami Y, Takeda K, Matsuo K, Nagano Y, Tanaka K, Ichikawa Y, Togo S, Kunisaki C, Shimada H.

World J Surg. 2009 Jan;33(1):104-10. doi: 10.1007/s00268-008-9807-2.

PMID:
19011933

Supplemental Content

Support Center